BPMC News Today: Stay Updated with the Latest Blueprint Medicines Corporation News in Real Time
Find BPMC news now at Meyka AI. Stay informed with the latest Blueprint Medicines Corporation stocks updates, including price news, market analysis, and expert insights.
NVIDIA Corp (NVDA -0.22% / -1.78% Pre-Market) Leads AI Chip Stocks Drop as AMD (-3.02%), Intel (-2.13%), and Micron (-1.41%) Decline
NVIDIA shares fell 1.78% in pre-market trading on June 10, 2026, leading a broader decline across AI chip stocks. AMD dropped 3.02%, while Intel and Micron also traded lower as investors reacted to renewed concerns over inflation, interest rates, and technology valuations. The selloff comes after a powerful AI-driven rally that pushed semiconductor stocks to…
Concord Biotech Shares Jump 5.9% After US FDA Approves Tofacitinib Arthritis Drug
Shares of Concord Biotech saw strong buying interest after a key global development. The stock rose around 5.9% in recent trading sessions after news of a US FDA approval related to its Tofacitinib-based arthritis drug. The trigger is important. The US Food and Drug Administration (FDA) approval opens doors to the world’s largest pharmaceutical market….
Toyota Motor Corp (TYO: 7203) Slips 0.57% (-16 JPY) After Filing Latest Securities Report in Japan
Toyota Motor Corp shares declined 0.57% or 16 JPY in recent trading after the company submitted its latest securities report in Japan. While the decline was relatively modest, investors closely monitored the filing for insights into the automaker’s financial position, business strategy, and future growth outlook. The movement reflects the cautious sentiment currently present across…
TELUS Stock Falls 0.8% as Dividend Yield Attracts Income Investors, June 09
TELUS stock at C$17.04 offers 9.8% dividend yield with C$20.27 analyst target. Meyka rates B- citing high debt concerns.
Parabilis Medicines Targets Up to $2.3 Billion Valuation in Expanded U.S. IPO Amid Biotech Market Rally
Parabilis Medicines is aiming for a valuation of nearly $2.3 billion through an expanded U.S. initial public offering, highlighting renewed investor confidence in the biotechnology sector. The Cambridge, Massachusetts-based company increased the size of its offering as demand for biotech IPOs continues to improve following a challenging period for the industry. The company now plans…
China Plans $295 Billion AI Infrastructure Push with 2 Trillion Yuan Data Center Investment
China is preparing a massive artificial intelligence infrastructure expansion worth nearly $295 billion, marking one of the largest AI investments ever announced. Reports on June 9, 2026, revealed plans to invest 2 trillion yuan in a nationwide network of data centers and computing hubs. The move highlights Beijing’s growing focus on AI leadership and technology…
GSK to Buy Nuvalent for $10.6 Billion, Paying $124 Per Share in All-Cash Deal
GSK has made a major move in the global pharmaceutical industry. The company has agreed to acquire Nuvalent for $10.6 billion in an all-cash deal. The offer price is $124 per share, which is about a 40% premium compared to the last closing price of Nuvalent. This is not a small deal. It is one…
South Korea Cabinet Approves Decree for $350 Billion U.S. Investment Plan
South Korea has taken a major step in implementing its $350 billion investment commitment to the United States after the Cabinet approved a presidential decree on June 9, 2026. The decision creates the legal framework needed to launch one of the largest overseas investment programs ever backed by Seoul. The package includes $200 billion for…
Apollo and Blackstone Commit $35 Billion to Anthropic’s AI Infrastructure
Apollo Global Management and Blackstone have finalized a $35 billion financing package for Anthropic, marking one of the largest private credit transactions in AI history. The funding will help Anthropic secure advanced AI computing infrastructure, primarily through Google’s custom Tensor Processing Units, known as TPUs, which are essential for training and running large language models…